Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.

Auteurs Genin EC, Bannwarth S, Lespinasse F, Ortega-Vila B, Fragaki K, Itoh K, Villa E, Lacas-Gervais S, Jokela M, Auranen M, Ylikallio E, Mauri-Crouzet A, Tyynismaa H, Vihola A, Augé G, Cochaud C, Sesaki H, Ricci JE, Udd B, Vives-Bauza C, Paquis-Flucklinger V

Neurobiology of disease Nov 2018

Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.

Auteurs Berthe A, Zaffino M, Muller C, Foulquier F, Houdou M, Schulz C, Bost F, De Fay E, Mazerbourg S, Flament S

Breast cancer research and treatment Oct 2018

Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.

Auteurs Lebeaupin C, Vallée D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B

Journal of hepatology Oct 2018

Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation.

Auteurs Jacquel A, Luciano F, Robert G, Auberger P

International journal of molecular sciences Sep 2018

Metformin: Focus on Melanoma.

Auteurs Jaune E, Rocchi S

Frontiers in endocrinology Août 2018

Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production.

Auteurs Sawaki D, Czibik G, Pini M, Ternacle J, Suffee N, Mercedes R, Marcelin G, Surenaud M, Marcos E, Gual P, Clément K, Hue S, Adnot S, Hatem SN, Tsuchimochi I, Yoshimitsu T, Hénégar C, Derumeaux G

Circulation Août 2018

A kindred with mutant IKAROS and autoimmunity.

Auteurs Van Nieuwenhove E, Garcia-Perez JE, Helsen C, Rodriguez PD, van Schouwenburg PA, Dooley J, Schlenner S, van der Burg M, Verhoeyen E, Gijsbers R, Frietze S, Schjerven H, Meyts I, Claessens F, Humblet-Baron S, Wouters C, Liston A

The Journal of allergy and clinical immunology Août 2018

Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.

Auteurs Zeng H, Jorapur A, Shain AH, Lang UE, Torres R, Zhang Y, McNeal AS, Botton T, Lin J, Donne M, Bastian IN, Yu R, North JP, Pincus L, Ruben BS, Joseph NM, Yeh I, Bastian BC, Judson RL

Cancer cell Jul 2018

Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.

Auteurs Didier R, Mallavialle A, Ben Jouira R, Domdom MA, Tichet M, Auberger P, Luciano F, Ohanna M, Tartare-Deckert S, Deckert M

Molecular cancer therapeutics Juil 2018

Reshaping the Immune Tumor Microenvironment Through IRE1 Signaling.

Auteurs Rubio-Patiño C, Bossowski JP, Chevet E, Ricci JE

Trends in molecular medicine Juil 2018